Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Coronary Aneurysm | 2 | 2020 | 132 | 1.40 | Why? |
| Respiratory Syncytial Virus Infections | 5 | 2018 | 1234 | 1.01 | Why? |
| Picornaviridae Infections | 2 | 2019 | 544 | 0.97 | Why? |
| Respiratory Sounds | 4 | 2019 | 294 | 0.91 | Why? |
| Maternal Nutritional Physiological Phenomena | 1 | 2019 | 39 | 0.78 | Why? |
| Drug Resistance | 2 | 2018 | 395 | 0.76 | Why? |
| Mastoiditis | 1 | 2018 | 7 | 0.76 | Why? |
| Esophageal Stenosis | 1 | 2018 | 21 | 0.74 | Why? |
| Serogroup | 2 | 2019 | 510 | 0.73 | Why? |
| Respiratory Hypersensitivity | 1 | 2019 | 103 | 0.71 | Why? |
| Bronchiolitis | 2 | 2019 | 297 | 0.69 | Why? |
| Esophagoscopy | 1 | 2018 | 95 | 0.68 | Why? |
| Otitis Media | 1 | 2018 | 106 | 0.66 | Why? |
| Administrative Personnel | 1 | 2020 | 326 | 0.65 | Why? |
| Radiation Exposure | 1 | 2018 | 161 | 0.64 | Why? |
| Mucocutaneous Lymph Node Syndrome | 2 | 2018 | 1645 | 0.64 | Why? |
| Bronchiolitis, Viral | 1 | 2017 | 71 | 0.63 | Why? |
| Esophagus | 1 | 2018 | 139 | 0.63 | Why? |
| Rhinovirus | 2 | 2019 | 979 | 0.61 | Why? |
| Asthma | 4 | 2019 | 4383 | 0.59 | Why? |
| Respiratory Syncytial Virus, Human | 4 | 2018 | 846 | 0.59 | Why? |
| Foreign Bodies | 1 | 2018 | 171 | 0.57 | Why? |
| Diet, Mediterranean | 1 | 2019 | 351 | 0.55 | Why? |
| Infant | 22 | 2021 | 30274 | 0.53 | Why? |
| Child Health | 2 | 2019 | 940 | 0.49 | Why? |
| Parents | 3 | 2021 | 2758 | 0.48 | Why? |
| Chilblains | 2 | 2021 | 1156 | 0.48 | Why? |
| Allergens | 1 | 2017 | 728 | 0.44 | Why? |
| Child | 25 | 2021 | 70012 | 0.44 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.44 | Why? |
| Immunoglobulins, Intravenous | 2 | 2018 | 2705 | 0.39 | Why? |
| Sleep Wake Disorders | 1 | 2021 | 1463 | 0.39 | Why? |
| Perception | 1 | 2020 | 2827 | 0.38 | Why? |
| Patient Compliance | 1 | 2019 | 1468 | 0.38 | Why? |
| Prenatal Care | 1 | 2019 | 1314 | 0.37 | Why? |
| Infant, Premature, Diseases | 1 | 2008 | 74 | 0.34 | Why? |
| Immunity, Cellular | 2 | 2019 | 3614 | 0.33 | Why? |
| Hypersensitivity | 1 | 2017 | 1137 | 0.33 | Why? |
| Cytomegalovirus Infections | 2 | 2017 | 667 | 0.33 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.32 | Why? |
| Italy | 16 | 2021 | 38444 | 0.32 | Why? |
| Child, Preschool | 14 | 2021 | 36283 | 0.31 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.28 | Why? |
| Schools | 1 | 2020 | 4187 | 0.27 | Why? |
| Pediatrics | 3 | 2021 | 2969 | 0.27 | Why? |
| Infant, Newborn | 12 | 2020 | 23105 | 0.26 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.26 | Why? |
| Ultrasonography | 2 | 2020 | 4409 | 0.25 | Why? |
| Radiography, Thoracic | 2 | 2020 | 5486 | 0.24 | Why? |
| Roseolovirus Infections | 1 | 2003 | 131 | 0.24 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.24 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.23 | Why? |
| Acute Disease | 3 | 2020 | 6029 | 0.23 | Why? |
| Herpesvirus 6, Human | 1 | 2003 | 162 | 0.22 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.22 | Why? |
| Skin Diseases, Genetic | 1 | 2021 | 65 | 0.22 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.21 | Why? |
| Dermatitis, Exfoliative | 1 | 2020 | 50 | 0.20 | Why? |
| Dimensional Measurement Accuracy | 1 | 2018 | 56 | 0.19 | Why? |
| Dilatation, Pathologic | 1 | 2018 | 78 | 0.19 | Why? |
| Foot Dermatoses | 1 | 2020 | 112 | 0.19 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.18 | Why? |
| Valsalva Maneuver | 1 | 2017 | 17 | 0.18 | Why? |
| Parenteral Nutrition, Home | 1 | 2018 | 68 | 0.18 | Why? |
| Recurrence | 3 | 2018 | 3675 | 0.18 | Why? |
| Inflammation | 2 | 2019 | 13255 | 0.17 | Why? |
| Tachycardia, Supraventricular | 1 | 2017 | 52 | 0.17 | Why? |
| Dilatation | 1 | 2018 | 181 | 0.16 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.16 | Why? |
| Erythema | 1 | 2021 | 400 | 0.16 | Why? |
| Humans | 38 | 2021 | 930598 | 0.16 | Why? |
| Histamine Antagonists | 1 | 2018 | 203 | 0.16 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.15 | Why? |
| Hand Dermatoses | 1 | 2020 | 284 | 0.15 | Why? |
| Female | 21 | 2021 | 380317 | 0.15 | Why? |
| Enteral Nutrition | 1 | 2018 | 320 | 0.15 | Why? |
| Reoperation | 1 | 2018 | 544 | 0.15 | Why? |
| Male | 19 | 2021 | 367725 | 0.14 | Why? |
| Serum Albumin | 1 | 2018 | 571 | 0.14 | Why? |
| Biopsy | 2 | 2021 | 2811 | 0.14 | Why? |
| Seizures | 1 | 2003 | 1163 | 0.14 | Why? |
| Societies, Medical | 1 | 2010 | 6907 | 0.13 | Why? |
| Vomiting | 1 | 2018 | 722 | 0.13 | Why? |
| Risk Factors | 9 | 2021 | 71621 | 0.13 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.12 | Why? |
| Systemic Inflammatory Response Syndrome | 3 | 2021 | 6653 | 0.12 | Why? |
| Abdominal Pain | 1 | 2018 | 858 | 0.12 | Why? |
| Platelet Count | 1 | 2018 | 1381 | 0.12 | Why? |
| Cytomegalovirus | 1 | 2017 | 600 | 0.12 | Why? |
| Cross-Sectional Studies | 5 | 2021 | 53120 | 0.11 | Why? |
| Measles | 1 | 2019 | 608 | 0.11 | Why? |
| Sensitivity and Specificity | 4 | 2018 | 22971 | 0.11 | Why? |
| Emergency Service, Hospital | 3 | 2020 | 14232 | 0.10 | Why? |
| Taiwan | 1 | 2018 | 2556 | 0.10 | Why? |
| Lung | 1 | 2018 | 31049 | 0.10 | Why? |
| Social Determinants of Health | 1 | 2021 | 1757 | 0.09 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.09 | Why? |
| Delayed Diagnosis | 1 | 2018 | 1529 | 0.09 | Why? |
| Seasons | 2 | 2018 | 4071 | 0.09 | Why? |
| Anxiety Disorders | 1 | 2021 | 2290 | 0.09 | Why? |
| Life Style | 1 | 2020 | 2708 | 0.08 | Why? |
| Adaptive Immunity | 1 | 2019 | 2585 | 0.08 | Why? |
| Home Care Services | 1 | 2018 | 1351 | 0.08 | Why? |
| Retrospective Studies | 7 | 2020 | 105322 | 0.08 | Why? |
| Patient Positioning | 1 | 2017 | 1505 | 0.08 | Why? |
| Echocardiography | 1 | 2020 | 3661 | 0.08 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2003 | 5164 | 0.08 | Why? |
| Pregnancy Outcome | 1 | 2019 | 3803 | 0.07 | Why? |
| Practice Guidelines as Topic | 1 | 2010 | 15421 | 0.07 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.07 | Why? |
| Japan | 1 | 2018 | 6653 | 0.07 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.07 | Why? |
| Nervous System Diseases | 1 | 2003 | 4092 | 0.07 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2021 | 2963 | 0.07 | Why? |
| Cough | 1 | 2018 | 4891 | 0.07 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.07 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.07 | Why? |
| Infant Nutritional Physiological Phenomena | 1 | 2003 | 75 | 0.06 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.06 | Why? |
| Serologic Tests | 1 | 2017 | 4359 | 0.06 | Why? |
| Pregnancy | 3 | 2019 | 23879 | 0.06 | Why? |
| Hospitalization | 4 | 2018 | 54280 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Triage | 1 | 2020 | 7151 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.05 | Why? |
| DNA, Viral | 2 | 2017 | 2521 | 0.05 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.05 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.05 | Why? |
| Child Nutritional Physiological Phenomena | 1 | 2018 | 40 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Viral Vaccines | 1 | 2019 | 7560 | 0.04 | Why? |
| Iron | 1 | 2003 | 619 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 8811 | 0.04 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Measles virus | 1 | 2019 | 194 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.04 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Anemia | 1 | 2003 | 789 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| ROC Curve | 2 | 2019 | 6024 | 0.04 | Why? |
| Tobacco Smoke Pollution | 1 | 2018 | 181 | 0.04 | Why? |
| Neutropenia | 1 | 2019 | 388 | 0.04 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.04 | Why? |
| Encephalitis, Viral | 1 | 2019 | 355 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Respiratory Therapy | 1 | 2020 | 918 | 0.03 | Why? |
| Gestational Age | 1 | 2018 | 1488 | 0.03 | Why? |
| Antibody Affinity | 1 | 2017 | 1078 | 0.03 | Why? |
| Intensive Care Units, Pediatric | 1 | 2019 | 1098 | 0.03 | Why? |
| Pancreatitis | 1 | 2019 | 688 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Atypical Bacterial Forms | 1 | 2008 | 10 | 0.02 | Why? |
| Adult | 3 | 2020 | 244371 | 0.02 | Why? |
| Health Care Surveys | 1 | 2018 | 2942 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2003 | 6740 | 0.02 | Why? |
| Nutritional Status | 1 | 2018 | 1403 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.02 | Why? |
| Reagent Kits, Diagnostic | 1 | 2017 | 2149 | 0.02 | Why? |
| Family | 1 | 2021 | 2909 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.02 | Why? |
| Antiviral Agents | 1 | 2019 | 41703 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Food, Fortified | 1 | 2003 | 43 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Infant Formula | 1 | 2003 | 64 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| United States | 1 | 2010 | 46150 | 0.02 | Why? |
| Middle Aged | 1 | 2020 | 270681 | 0.01 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2017 | 9091 | 0.01 | Why? |
| Pregnancy Complications, Infectious | 1 | 2003 | 11559 | 0.01 | Why? |
| Depression | 1 | 2021 | 14116 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Anxiety | 1 | 2021 | 17311 | 0.01 | Why? |
| Bacterial Infections | 1 | 2008 | 2229 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2019 | 48226 | 0.01 | Why? |
| Viral Load | 1 | 2008 | 15850 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2017 | 51949 | 0.00 | Why? |